MX2014014791A - Metodos para diagnosticar la enfermedad valvular cronica. - Google Patents

Metodos para diagnosticar la enfermedad valvular cronica.

Info

Publication number
MX2014014791A
MX2014014791A MX2014014791A MX2014014791A MX2014014791A MX 2014014791 A MX2014014791 A MX 2014014791A MX 2014014791 A MX2014014791 A MX 2014014791A MX 2014014791 A MX2014014791 A MX 2014014791A MX 2014014791 A MX2014014791 A MX 2014014791A
Authority
MX
Mexico
Prior art keywords
sample
valvular disease
animal
chronic valvular
methods
Prior art date
Application number
MX2014014791A
Other languages
English (en)
Other versions
MX358561B (es
Inventor
Dorothy P Laflamme
Steven S Hannah
Qinghong Li
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2014014791A publication Critical patent/MX2014014791A/es
Publication of MX358561B publication Critical patent/MX358561B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

La invención proporciona métodos para diagnosticar la enfermedad valvular crónica en un animal. Los métodos comprenden obtener una muestra del animal; analizar la muestra para identificar la presencia de uno o más metabolitos asociados con la enfermedad valvular crónica; comparar la cantidad de cada uno de tales metabolitos identificados en la muestra, con una cantidad correspondiente del mismo metabolito, presente en una muestra a partir de uno o más animales de control comparables, que no sufren de enfermedad valvular crónica; y utilizar dicha comparación para diagnosticar la enfermedad valvular crónica en el animal, si los metabolitos que se encuentran en la muestra del animal son mas que o menos que la cantidad presente en la muestra del animal de control.
MX2014014791A 2012-06-05 2013-06-04 Métodos para diagnosticar la enfermedad valvular crónica. MX358561B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261655704P 2012-06-05 2012-06-05
PCT/US2013/044008 WO2013184628A1 (en) 2012-06-05 2013-06-04 Methods for diagnosing chronic valvular disease

Publications (2)

Publication Number Publication Date
MX2014014791A true MX2014014791A (es) 2015-02-24
MX358561B MX358561B (es) 2018-08-24

Family

ID=48626663

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014791A MX358561B (es) 2012-06-05 2013-06-04 Métodos para diagnosticar la enfermedad valvular crónica.

Country Status (12)

Country Link
US (1) US20150153353A1 (es)
EP (1) EP2856170B1 (es)
JP (1) JP6174689B2 (es)
CN (1) CN104364658B (es)
AU (1) AU2013271879B2 (es)
BR (1) BR112014030243B1 (es)
CA (1) CA2875331C (es)
ES (1) ES2687979T3 (es)
IN (1) IN2014DN10127A (es)
MX (1) MX358561B (es)
RU (1) RU2667634C2 (es)
WO (1) WO2013184628A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3387446A2 (en) * 2015-12-07 2018-10-17 Zora Biosciences OY Use of ceramides and lpls in diagnosing cvd

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
AU2009243094B2 (en) * 2006-11-06 2015-02-12 Massachusetts Institute Of Technology Immunomodulating compositions and methods of use thereof
ES2443540T3 (es) * 2007-07-17 2014-02-19 Metabolon, Inc. Biomarcadores para pre-diabetes y métodos que usan los mismos
WO2009062169A2 (en) * 2007-11-09 2009-05-14 The Board Of Regents Of The University Of Texas System Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
JP2011520118A (ja) * 2008-05-07 2011-07-14 ユニバーシティ オブ ストラスクライド 細胞の評価方法、評価システムおよび埋め込み型装置
RU2011135768A (ru) * 2009-01-29 2013-03-10 Эбботт Лэборетриз Белки, связывающие il-1
BR112013001752A2 (pt) * 2010-07-23 2016-05-31 Harvard College método de detectar doenças ou condições usando células fagocídicas

Also Published As

Publication number Publication date
CN104364658B (zh) 2017-06-30
AU2013271879A1 (en) 2014-12-18
AU2013271879B2 (en) 2019-03-28
CA2875331A1 (en) 2013-12-12
MX358561B (es) 2018-08-24
ES2687979T3 (es) 2018-10-30
BR112014030243A2 (pt) 2017-06-27
US20150153353A1 (en) 2015-06-04
RU2014153109A (ru) 2016-08-10
IN2014DN10127A (es) 2015-08-21
JP6174689B2 (ja) 2017-08-02
CN104364658A (zh) 2015-02-18
JP2015524066A (ja) 2015-08-20
CA2875331C (en) 2022-11-29
BR112014030243B1 (pt) 2022-07-05
EP2856170A1 (en) 2015-04-08
RU2667634C2 (ru) 2018-09-21
WO2013184628A1 (en) 2013-12-12
EP2856170B1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
MX2019005748A (es) Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
EP3587597C0 (en) METHOD FOR DIAGNOSING PARKINSON'S DISEASE BY BACTERIAL METAGENOME ANALYSIS
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
BR112015003046A2 (pt) sistema de neurofeedback, processador de sinal para determinação de uma característica do sinal do sinal do biofeedback medido, método para provisão de um usuário com o neurofeedback e programa de computador.
WO2015034886A3 (en) Wellness panel for companion animals
MX2016016742A (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
MX2016004167A (es) Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal.
EP3567118A4 (en) METHOD OF DIAGNOSING HEART DISEASES BY BACTERIAL METAGENOMANALYSIS
WO2012122374A3 (en) Non-invasive methods for diagnosing chronic organ transplant rejection
MX2016005854A (es) Anticuerpo anti-her3 alosterico de la neuregulina.
EP3029595A3 (en) Apparatuses, mobile devices, methods and computer programs for evaluating runtime information of an extracted set of instructions based on at least a part of a computer program
MX2015015015A (es) Metodo para diagnosticar cancer.
MX2016009490A (es) Ensayo novedoso para detectar periostina humana.
IN2013CH05587A (es)
WO2016012864A3 (en) Biomarkers for anderson-fabry disease
NZ720608A (en) Β-glucan assay methods
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
IN2014DN10127A (es)
BR112017027304A2 (pt) método para o diagnóstico de doença de farber
MX2017010352A (es) Metodos para diagnosticar enfermedad valvular cronica.

Legal Events

Date Code Title Description
FG Grant or registration